These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 28129239

  • 1. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
    Cho HY, Kim K, Kim YB, Kim H, No JH.
    Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
    [Abstract] [Full Text] [Related]

  • 2. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL.
    Int J Clin Exp Pathol; 2015 Mar; 8(5):5642-9. PubMed ID: 26191276
    [Abstract] [Full Text] [Related]

  • 3. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.
    Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II.
    Clin Cancer Res; 2010 Jul 15; 16(14):3743-53. PubMed ID: 20534738
    [Abstract] [Full Text] [Related]

  • 4. [Expression patterns and prognostic values of Nrf2 and Keap1 in nasopharyngeal carcinoma].
    Ma XK, Liu JS.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May 15; 32(9):678-682. PubMed ID: 29771085
    [Abstract] [Full Text] [Related]

  • 5. Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Martín de la Fuente L, Malander S, Hartman L, Jönsson JM, Ebbesson A, Nilbert M, Måsbäck A, Hedenfalk I.
    Int J Gynecol Pathol; 2018 Mar 15; 37(2):101-109. PubMed ID: 28481779
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A, Matiur Rahaman M, Chen M, Tang X.
    BMC Cancer; 2018 Jan 06; 18(1):46. PubMed ID: 29306329
    [Abstract] [Full Text] [Related]

  • 9. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J, Haapasaari KM, Soini Y, Karihtala P.
    Diagn Pathol; 2015 Apr 16; 10():28. PubMed ID: 25879528
    [Abstract] [Full Text] [Related]

  • 10. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E, Kangaskokko J, Puistola U, Karihtala P.
    Tumour Biol; 2019 Jan 16; 41(1):1010428318815413. PubMed ID: 30803422
    [Abstract] [Full Text] [Related]

  • 11. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
    Paek J, Lee M, Nam EJ, Kim SW, Kim YT.
    Arch Gynecol Obstet; 2016 Mar 16; 293(3):645-50. PubMed ID: 26305032
    [Abstract] [Full Text] [Related]

  • 12. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
    Wong TF, Yoshinaga K, Monma Y, Ito K, Niikura H, Nagase S, Yamamoto M, Yaegashi N.
    Int J Gynecol Cancer; 2011 Nov 16; 21(8):1428-35. PubMed ID: 21897267
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA.
    J Cancer Res Clin Oncol; 2016 May 16; 142(5):949-58. PubMed ID: 26762850
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J, Jiao Q, Kong L, Yu J, Fang A, Li M, Yu J.
    Thorac Cancer; 2018 Jun 16; 9(6):726-735. PubMed ID: 29675925
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
    Cáceres-Gorriti KY, Carmona E, Barrès V, Rahimi K, Létourneau IJ, Tonin PN, Provencher D, Mes-Masson AM.
    PLoS One; 2014 Jun 16; 9(3):e91000. PubMed ID: 24625450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.